| scholarly article | Q13442814 |
| P50 | author | Sarah Spiegel | Q20950329 |
| Carole A Oskeritzian | Q87091469 | ||
| P2093 | author name string | Michael A Beaven | |
| Poulami Mitra | |||
| Shawn G Payne | |||
| Sheldon Milstien | |||
| P2860 | cites work | MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine | Q24317572 |
| Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling | Q24337047 | ||
| Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells | Q28202691 | ||
| PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA) | Q28215068 | ||
| Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells | Q28275578 | ||
| Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor | Q28344451 | ||
| Functional expression of the multidrug resistance protein 1 in microglia | Q28568213 | ||
| IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses | Q28586614 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells | Q30830927 | ||
| Discovery and evaluation of inhibitors of human sphingosine kinase | Q31004970 | ||
| Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility | Q32075112 | ||
| The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology | Q33652544 | ||
| The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. | Q33770369 | ||
| Sphingolipid transport: rafts and translocators. | Q34128462 | ||
| The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 | Q34274256 | ||
| Role of sphingosine kinase 2 in cell migration toward epidermal growth factor | Q34425898 | ||
| The MRP family of drug efflux pumps | Q35567296 | ||
| Lysophospholipid G protein-coupled receptors | Q35692411 | ||
| Point-counterpoint of sphingosine 1-phosphate metabolism | Q35732398 | ||
| Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors | Q35847409 | ||
| Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 | ||
| Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists | Q36370341 | ||
| Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis | Q36399383 | ||
| Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase | Q37515328 | ||
| FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes | Q39741057 | ||
| Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages | Q40306295 | ||
| Sphingosine kinase 1 is up-regulated in colon carcinogenesis | Q40345686 | ||
| Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway | Q40437971 | ||
| Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. | Q40640528 | ||
| Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump | Q40999304 | ||
| Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor | Q41205257 | ||
| Expression of P-glycoprotein, encoded by MDR 1 gene, a metabolically active efflux pump in murine mast cells | Q41213378 | ||
| Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. | Q41577951 | ||
| The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering | Q42136631 | ||
| The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane | Q42466401 | ||
| Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma | Q43601724 | ||
| Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells | Q43742293 | ||
| Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells | Q44430440 | ||
| Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis | Q44899592 | ||
| Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells | Q44951894 | ||
| Sphingolipids and the balancing of immune cell function: lessons from the mast cell | Q45231986 | ||
| Enzymatic measurement of sphingosine 1-phosphate | Q48163685 | ||
| MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes | Q67267224 | ||
| Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein | Q73851378 | ||
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mast cell | Q191989 |
| ATP binding cassette subfamily C member 1 | Q21122407 | ||
| sphingolipid translocation | Q26250722 | ||
| P304 | page(s) | 16394-9 | |
| P577 | publication date | 2006-10-31 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Role of ABCC1 in export of sphingosine-1-phosphate from mast cells | |
| P478 | volume | 103 |
| Q34593159 | "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets |
| Q37106169 | A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). |
| Q33988392 | A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders |
| Q44933196 | A rapid and sensitive method to measure secretion of sphingosine-1-phosphate |
| Q27009351 | A review of ceramide analogs as potential anticancer agents |
| Q36835151 | A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. |
| Q47118535 | ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. |
| Q37595188 | ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer |
| Q43193922 | ABC transporters in cancer: more than just drug efflux pumps. |
| Q52663621 | ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. |
| Q58798114 | ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? |
| Q58122091 | Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis |
| Q24628769 | An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown |
| Q35545433 | An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease |
| Q34402916 | An update on sphingosine-1-phosphate and other sphingolipid mediators |
| Q33945064 | An update on the biology of sphingosine 1-phosphate receptors. |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q51663836 | ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner. |
| Q47124953 | Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes |
| Q36804936 | Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal |
| Q27000801 | Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) |
| Q38605015 | Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation |
| Q36237907 | Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism |
| Q37612339 | Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation |
| Q37619251 | Ceramide signaling in mammalian epidermis |
| Q37371999 | Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes |
| Q38204272 | Chemical and genetic tools to explore S1P biology |
| Q35684358 | Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules |
| Q41622885 | Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer |
| Q44091518 | Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes |
| Q35351053 | Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration |
| Q37145587 | Cross-linking of FcepsilonRI causes Ca2+ mobilization via a sphingosine kinase pathway in a clathrin-dependent manner |
| Q36727413 | Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling |
| Q34662206 | CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells |
| Q35357091 | Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice |
| Q48214417 | DNA Methylation and the Potential Role of Methyl-Containing Nutrients in Cardiovascular Diseases. |
| Q38619642 | DNA damage response and sphingolipid signaling in liver diseases |
| Q97423660 | Decoding the Role of Sphingosine-1-Phosphate in Asthma and Other Respiratory System Diseases Using Next Generation Knowledge Discovery Platforms Coupled With Luminex Multiple Analyte Profiling Technology |
| Q35019936 | Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist |
| Q37830235 | Dissecting the role of the S1P/S1PR axis in health and disease. |
| Q34272235 | Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions |
| Q38296149 | Downregulation of Sphingosine 1-Phosphate Receptor 1 Promotes the Switch from Tangential to Radial Migration in the OB. |
| Q37341131 | Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis |
| Q36867184 | Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload |
| Q33730147 | Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema |
| Q33796082 | Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. |
| Q37408557 | Export and functions of sphingosine-1-phosphate. |
| Q27009557 | Export of sphingosine-1-phosphate and cancer progression |
| Q34183703 | Extracellular and Intracellular Actions of Sphingosine-1-Phosphate |
| Q42569152 | FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration |
| Q38820716 | Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling |
| Q37008187 | Finding a way out: lymphocyte egress from lymphoid organs |
| Q37071009 | Functional diversification of sea urchin ABCC1 (MRP1) by alternative splicing |
| Q36168847 | G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation |
| Q33831886 | Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain |
| Q34735060 | Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice |
| Q52686040 | Identification of Chloride Channels CLCN3 and CLCN5 Mediating the Excitatory Cl- Currents Activated by Sphingosine-1-Phosphate in Sensory Neurons. |
| Q39404395 | Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase |
| Q38871772 | Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells |
| Q36698606 | Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset |
| Q28743138 | Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase |
| Q38001734 | Investigational ABC transporter inhibitors |
| Q36369205 | Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes |
| Q46049440 | Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone |
| Q34540244 | Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage |
| Q52643925 | MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells. |
| Q34482185 | Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer |
| Q48348142 | Mast cells and sphingosine-1-phosphate underlie prelesional remodeling in a mouse model of eczema |
| Q44933193 | Measurement of mammalian sphingosine-1-phosphate phosphohydrolase activity in vitro and in vivo |
| Q51006830 | Methods for Analyzing Sphingosine-1-Phosphate Signaling in Human and Mouse Primary Mast Cells. |
| Q64963613 | Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases. |
| Q30525710 | Molecular mechanisms of spontaneous and directed mast cell motility |
| Q38216015 | Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis |
| Q34314035 | Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells |
| Q36655374 | Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers |
| Q34467407 | Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter |
| Q41829826 | Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. |
| Q33891067 | N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier |
| Q39907311 | Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein |
| Q37260865 | New insights on mast cell activation via the high affinity receptor for IgE |
| Q92012755 | Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases |
| Q48156024 | Nuclear Translocation of SGPP-1 and Decrease of SGPL-1 Activity Contribute to Sphingolipid Rheostat Regulation of Inflammatory Dendritic Cells. |
| Q38092176 | Oncogenic properties of sphingosine kinases in haematological malignancies. |
| Q37041271 | P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells |
| Q49554117 | Pharmacological Intervention to Modulate HDL: What Do We Target? |
| Q28265743 | Principles of bioactive lipid signalling: lessons from sphingolipids |
| Q38505992 | Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression |
| Q36237338 | Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. |
| Q38119472 | Quantitative metabolic profiling of lipid mediators. |
| Q36715339 | Regulation and functional roles of sphingosine kinases |
| Q34194335 | Regulation of Ca2+ signaling with particular focus on mast cells |
| Q57302349 | Regulation of Immune Cell Migration by Sphingosine-1-Phosphate |
| Q35551835 | Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors |
| Q37960383 | Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells |
| Q28297610 | RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells |
| Q39355430 | Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA. |
| Q57177438 | Role of sphingolipids in senescence: implication in aging and age-related diseases |
| Q37871354 | Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein |
| Q42283814 | Role of sphingosine kinase localization in sphingolipid signaling |
| Q41883393 | Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone |
| Q34879183 | Roles of sphingosine 1-phosphate on tumorigenesis |
| Q91738678 | Roles of sphingosine-1-phosphate signaling in cancer |
| Q48247517 | S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling |
| Q38626918 | S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1β or Lipocalin-2. |
| Q89587308 | S1P Signaling in the Tumor Microenvironment |
| Q54963902 | S1P₄ Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells. |
| Q26998940 | STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer |
| Q36356934 | Shaping the landscape: metabolic regulation of S1P gradients |
| Q35776618 | Sources, metabolism, and regulation of circulating sphingosine-1-phosphate |
| Q35222194 | Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle |
| Q35675184 | Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond |
| Q26992148 | Sphingolipid signaling in metabolic disorders |
| Q89977951 | Sphingolipids and Mitochondrial Dynamic |
| Q64965708 | Sphingolipids as Emerging Mediators in Retina Degeneration. |
| Q37447464 | Sphingolipids in inflammation: pathological implications and potential therapeutic targets. |
| Q21296721 | Sphingolipids: a potential molecular approach to treat allergic inflammation |
| Q41547434 | Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. |
| Q34121255 | Sphingosine 1-phosphate and cancer |
| Q33855307 | Sphingosine 1-phosphate and sphingosine kinase are involved in a novel signaling pathway leading to acrosomal exocytosis |
| Q38170107 | Sphingosine 1-phosphate axis: a new leader actor in skeletal muscle biology. |
| Q37909176 | Sphingosine 1-phosphate in coagulation and inflammation. |
| Q33918167 | Sphingosine 1-phosphate induces differentiation of mesoangioblasts towards smooth muscle. A role for GATA6 |
| Q34474499 | Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype |
| Q27024207 | Sphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss? |
| Q37845445 | Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells |
| Q38185438 | Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? |
| Q45072762 | Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism. |
| Q38013700 | Sphingosine kinase 1 in viral infections. |
| Q36901428 | Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. |
| Q33715344 | Sphingosine kinase and sphingosine 1-phosphate in cardioprotection |
| Q38177794 | Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease |
| Q37328806 | Sphingosine kinase regulation and cardioprotection |
| Q28069459 | Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment |
| Q52598359 | Sphingosine-1-Phosphate Pathway in Renal Fibrosis. |
| Q26775993 | Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation |
| Q55564395 | Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis. |
| Q36537740 | Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2 |
| Q36240870 | Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function |
| Q28235893 | Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection |
| Q36151548 | Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis |
| Q26852824 | Sphingosine-1-phosphate in chronic intestinal inflammation and cancer |
| Q39407317 | Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells |
| Q54342529 | Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. |
| Q38448843 | Sphingosine-1-phosphate metabolism: A structural perspective |
| Q39485300 | Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cells |
| Q35146069 | Sphingosine-1-phosphate receptor 2 |
| Q30440476 | Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease |
| Q35661485 | Sphingosine-1-phosphate signaling and its role in disease |
| Q92279683 | Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases |
| Q37358457 | Sphingosine-1-phosphate synthesis and functions in mast cells |
| Q42181059 | Sphingosine-1-phosphate transporters as targets for cancer therapy. |
| Q46119380 | Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor |
| Q38166250 | Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity |
| Q37173184 | Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling |
| Q28591658 | Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network |
| Q37172893 | Targeting SphK1 as a new strategy against cancer |
| Q52592917 | Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT. |
| Q36300887 | Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain |
| Q38392764 | Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes |
| Q39379449 | Targeting sphingosine-1-phosphate signaling for cancer therapy |
| Q38952840 | Targeting sphingosine-1-phosphate signaling in lung diseases |
| Q36868420 | Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors |
| Q61450263 | The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis |
| Q26748848 | The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined |
| Q34150336 | The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720 |
| Q37010807 | The alliance of sphingosine-1-phosphate and its receptors in immunity |
| Q38038151 | The functional roles of S1P in immunity |
| Q28253643 | The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications |
| Q36011196 | The outs and the ins of sphingosine-1-phosphate in immunity |
| Q39656316 | The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation |
| Q38071694 | The role of sphingolipids in drug metabolism and transport |
| Q90024070 | The role of sphingosine kinase 2 in alcoholic liver disease |
| Q37128721 | The role of sphingosine-1-phosphate and its receptors in asthma |
| Q36241051 | The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. |
| Q57153732 | The role of sphingosine-1-phosphate in inflammation and cancer progression |
| Q38734489 | The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications. |
| Q24599540 | The role of sphingosine-1-phosphate transporter Spns2 in immune system function |
| Q90492446 | The signalling roles of sphingosine-1-phosphate derived from red blood cells and platelets |
| Q28588851 | The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice |
| Q35306259 | The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. |
| Q42551908 | The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. |
| Q39589659 | The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate |
| Q37085319 | The vascular S1P gradient-cellular sources and biological significance |
| Q38915115 | Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism |
| Q37930972 | Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer |
| Q26771645 | Trafficking and Functions of Bioactive Sphingolipids: Lessons from Cells and Model Membranes |
| Q64944377 | Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics. |
| Q36724917 | Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model |
| Q43076657 | Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts. |
| Q36625179 | Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined |
| Q33880223 | Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient |
| Q37293908 | Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation |
| Q33378571 | Vascular endothelium as a contributor of plasma sphingosine 1-phosphate |
Search more.